European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention–2022 update S Sacco, FM Amin, M Ashina, L Bendtsen, CI Deligianni, R Gil-Gouveia, ... The journal of headache and pain 23 (1), 67, 2022 | 222 | 2022 |
Cognitive dysfunction during migraine attacks: a study on migraine without aura R Gil-Gouveia, AG Oliveira, IP Martins Cephalalgia 35 (8), 662-674, 2015 | 98 | 2015 |
Migraine, headaches, and cognition IP Martins, R Gil‐Gouveia, C Silva, C Maruta, AG Oliveira Headache: The Journal of Head and Face Pain 52 (10), 1471-1482, 2012 | 82 | 2012 |
Kinesiophobia in migraine IP Martins, RG Gouveia, E Parreira the Journal of Pain 7 (6), 445-451, 2006 | 76 | 2006 |
Headaches associated with refractive errors: myth or reality? R Gil‐Gouveia, IP Martins Headache: The Journal of Head and Face Pain 42 (4), 256-262, 2002 | 73 | 2002 |
Secondary “hypnic headache R Gil-Gouveia, PJ Goadsby Journal of neurology 254, 646-654, 2007 | 69 | 2007 |
The impact of cognitive symptoms on migraine attack-related disability R Gil-Gouveia, AG Oliveira, IP Martins Cephalalgia 36 (5), 422-430, 2016 | 67 | 2016 |
Clinical description of attack-related cognitive symptoms in migraine: a systematic review R Gil-Gouveia, IP Martins Cephalalgia 38 (7), 1335-1350, 2018 | 63 | 2018 |
Assessment of cognitive dysfunction during migraine attacks: a systematic review R Gil-Gouveia, AG Oliveira, IP Martins Journal of neurology 262, 654-665, 2015 | 63 | 2015 |
Early recanalization in patients with cerebral venous thrombosis treated with anticoagulation D Aguiar de Sousa, L Lucas Neto, A Arauz, AL Sousa, D Gabriel, ... Stroke 51 (4), 1174-1181, 2020 | 58 | 2020 |
Cognition and cognitive impairment in migraine R Gil-Gouveia, IP Martins Current pain and headache reports 23, 1-10, 2019 | 58 | 2019 |
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure S Sacco, C Lampl, FM Amin, M Braschinsky, C Deligianni, D Uludüz, ... The journal of headache and pain 23 (1), 133, 2022 | 44 | 2022 |
A subjective cognitive impairment scale for migraine attacks. The MIG-SCOG: development and validation R Gil-Gouveia, AG Oliveira, IP Martins Cephalalgia 31 (9), 984-991, 2011 | 43 | 2011 |
Validation of the Portuguese Version of ID‐Migraine™ R Gil‐Gouveia, I Martins Headache: The Journal of Head and Face Pain 50 (3), 396-402, 2010 | 43 | 2010 |
Pleomorphic xanthoastrocytoma of the cerebellum: illustrated review R Gil-Gouveia, N Cristino, JP Farias, A Trindade, NS Ruivo, J Pimentel Acta neurochirurgica 146, 1241-1244, 2004 | 41 | 2004 |
Headache service quality: evaluation of quality indicators in 14 specialist-care centres S Schramm, D Uluduz, RG Gouveia, R Jensen, A Siva, U Uygunoglu, ... The journal of headache and pain 17, 1-14, 2016 | 38 | 2016 |
Subjective cognitive symptoms during a migraine attack: a prospective study of a clinic-based sample R Gil-Gouveia, AG Oliveira, IP Martins Pain Physician 19 (1), E137, 2016 | 38 | 2016 |
Hypnic headache and travel across time zones: a case report IP Martins, RG Gouveia Cephalalgia 21 (9), 928-931, 2001 | 37 | 2001 |
The comparative effectiveness of migraine preventive drugs: a systematic review and network meta-analysis C Lampl, A MaassenVanDenBrink, CI Deligianni, R Gil-Gouveia, T Jassal, ... The journal of headache and pain 24 (1), 56, 2023 | 36 | 2023 |
Neuropsychiatric side-effects of lidocaine: examples from the treatment of headache and a review R Gil-Gouveia, PJ Goadsby Cephalalgia 29 (5), 496-508, 2009 | 36 | 2009 |